Neuraltus Pharmaceuticals Inc., a Menlo Park, Calif.-based developer of small-molecule drugs for neurodegenerative diseases, has raised $17 million in Series A funding. Backers include Latterell Venture Partners, VantagePoint Venture Partners and Adams Street Partners.
4 min read · 26 March 2009
Ripple TV, an El Segundo, Calif.-based operator of screens in specialty retail locations, has raised $4 million from Draper Fisher Jurvetson and Trinity Ventures.
3 min read · 26 March 2009
New Leaf Paper, an environmentally-friendly paper maker, has raised $5 million in VC funding led by Pacific Community Ventures.
3 min read · 26 March 2009
VaxInnate Corp., a Cranbury, N.J.-based developer of vaccines for both pandemic and seasonal influenza, is almost done raising $30 million in new Series C funding, according to VentureWire. The company held an initial $40 million close on the round back in 2006, led by New Leaf Venture Partners. Other backers include Canaan Partners and return backers HealthCare Ventures, Oxford Bioscience Partners, MedImmune Ventures and CHL Medical Ventures. www.vaxinnate.com
1 min read · 26 March 2009
ReGear Life Sciences, a Pittsburgh-based maker of a therapeutic warming system, has raised $2.5 million in Series A funding from Pittsburgh Life Sciences Greenhouse and Innovation Works. It had previously raised $1 million from Stonewood Capital Management.
3 min read · 26 March 2009
Visible Measures Corp., a Boston-based company that measures the behavior of online video audiences, has raised $10 million in Series C funding. Northgate Capital led the round, and was joined by return backers General Catalyst Partners and Mohr Davidow Ventures.
3 min read · 26 March 2009
UpSpring Baby, an Austin, Texas-based maker of products for the health, wellness and safety of infants, toddlers and parents, has raised $4 million in Series C funding. Small Ventures was joined by unnamed return backers, plus members of the Central Texas Angel Network.
2 min read · 26 March 2009
2 min read · 26 March 2009
1 min read · 25 March 2009
3 min read · 25 March 2009